|
AGPAT3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.77279999999691E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7856999999788E-06 |
| Normal-vs-Stage2 |
3.80749999995267E-06 |
| Normal-vs-Stage3 |
1.149220E-01 |
| Normal-vs-Stage4 |
1.53439999994731E-06 |
| Stage1-vs-Stage2 |
8.200000E-01 |
| Stage1-vs-Stage3 |
4.562300E-02 |
| Stage1-vs-Stage4 |
5.900600E-01 |
| Stage2-vs-Stage3 |
5.906000E-02 |
| Stage2-vs-Stage4 |
3.876200E-01 |
| Stage3-vs-Stage4 |
2.697800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.4440000000171E-06 |
| Normal-vs-AfricanAmerican |
1.016940E-04 |
| Normal-vs-Asian |
7.143600E-02 |
| Caucasian-vs-AfricanAmerican |
5.147900E-02 |
| Caucasian-vs-Asian |
5.210400E-01 |
| AfricanAmerican-vs-Asian |
8.838200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.68510000001054E-06 |
| Normal-vs-Female |
7.70950000000825E-05 |
| Male-vs-Female |
1.001750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.74979999999692E-05 |
| Normal-vs-Extreme_Weight |
3.04339999979142E-07 |
| Normal-vs-Obese |
2.045000E-04 |
| Normal-vs-Extreme_Obese |
9.617400E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.820400E-02 |
| Normal_Weight-vs-Obese |
6.182000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.273800E-01 |
| Extreme_Weight-vs-Obese |
9.023200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.595980E-01 |
| Obese-vs-Extreme_Obese |
8.341600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.015800E-03 |
| Normal-vs-Age(41-60Yrs) |
8.45339999999695E-07 |
| Normal-vs-Age(61-80Yrs) |
9.45589999967744E-07 |
| Normal-vs-Age(81-100Yrs) |
2.31829999974842E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.597800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.382400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.724230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.016410E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.038210E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.699570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.55709999969534E-07 |
| Normal-VS-Type2 PRCC |
5.965200E-04 |
| Normal-VS-KIRP CIMP |
1.436550E-04 |
| Normal-VS-Unclassified PRCC |
5.785000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.723640E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.153050E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.083840E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.677400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.650800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.425800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.583100E-03 |
| Normal-vs-N1 |
2.160700E-03 |
| Normal-vs-N2 |
4.672100E-02 |
| N0-vs-N1 |
9.513600E-01 |
| N0-vs-N2 |
6.181400E-01 |
| N1-vs-N2 |
5.196200E-01 |
|
|
